Sorrento Therapeutics (SRNEQ)

P/S ratio on April 27, 2023 (TTM) : 0.2573

According to Sorrento Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.0835. At the end of 2023 the company had a P/S ratio of 3.07.

P/S ratio history for Sorrento Therapeutics from 2010 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	3.07	-53.84%
2022	6.65	-75.94%
2021	27.6	-41.16%
2020	47.0	160.4%
2019	18.0	30.3%
2018	13.8	569.2%
2017	2.07	-94.06%
2016	34.8	-51.41%
2015	71.7	-24.76%
2014	95.3	-76.52%
2013	406	426.18%
2012	77.1	-18.32%
2011	94.4	-57.17%
2010	220

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Karyopharm Therapeutics KPTI	0.8793	241.70%	🇺🇸 USA
Exelixis EXEL	5.14	1,897.00%	🇺🇸 USA
Dicerna Pharmaceuticals DRNA	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Sorrento Therapeutics (SRNEQ)

P/S ratio on April 27, 2023 (TTM) : 0.2573